Join
Live feed
·
INSIDERFilingvia Quantisnow
Clovis Oncology Inc. logo

SEC Form 4: Rolfe Lindsey sold $6,326 worth of shares (4,330 units at $1.46) and converted options into 8,374 shares, increasing direct ownership by 4% to 107,060 units (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLVS (Clovis Oncology Inc.) and more on Quantisnow.